Product Information
METOCLOPRAMIDE 10 MG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.5290 per ML under NDC 00409525525. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jan 17, 1991. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the metoclopramide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Hospira Inc.NDC
00409525525
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
7/22/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA073118FDA Approved
1/17/1991
TE Code
AP
On Market Since
11/14/2022
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 2.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5290 per ML |
|---|---|
| All-time high | $0.6016 (May 14, 2025) |
| All-time low | $0.4971 (Jun 19, 2024) |
| 52-week high | $0.5732 |
| 52-week low | $0.5178 |
| Median price | $0.5472 |
| Average price | $0.5550 |
| Largest weekly change | +18.7% (Sep 18, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 10 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 10 MG/2 ML VIAL, manufactured by Hospira Inc., is $0.5290 per ML (NDC 00409525525), effective Aug 19, 2026.
How has the price of METOCLOPRAMIDE 10 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has declined 2.1%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 10 MG/2 ML VIAL?
Since Apr 17, 2024, the NADAC for METOCLOPRAMIDE 10 MG/2 ML VIAL has ranged from a low of $0.4971 (Jun 19, 2024) to a high of $0.6016 (May 14, 2025), with a median of $0.5472 per ML.
Are there cheaper alternatives to METOCLOPRAMIDE 10 MG/2 ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METOCLOPRAMIDE 10 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures METOCLOPRAMIDE 10 MG/2 ML VIAL?
METOCLOPRAMIDE 10 MG/2 ML VIAL (NDC 00409525525) is labeled by Hospira Inc., and CMS classifies it as a generic product.